Cryptococcosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2026

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Cryptococcosis Market Snapshot

4. Market Overview
4.1. Product Overview
4.2. Market Indicators
4.3. Global Cryptococcosis Market Size (US$ Mn) Forecast, 2014–2026
4.4. Global Cryptococcosis Market Outlook
4.5. Key Industry Events
4.6. Global Cryptococcosis Incidence Scenario-2015, by Region
4.7. Overview of Clinical Trials

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increasing incidence of cryptococcosis infections
5.2.2. Rising initiatives by government and non-government organizations
5.2.3. Impetus from HIV patients
5.2.4. Improved access to diagnostic facilities
5.3. Restraints
5.3.1. High mortality among cryptococcosis infected patients
5.3.2. Patent expiry of key drugs and entry of generics
5.4. Opportunity Analysis
5.5. Opportunities
5.5.1. Setting up integrated facilities in high-potential markets
5.5.2. Investment inflow and mergers & acquisitions

6. Global Cryptococcosis Market Analysis, by Treatment
6.1. Introduction
6.2. Key Findings
6.3. Global Cryptococcosis Market Value Share Analysis, by Treatment, 2016-2026
6.3.1. Amphotericin B
6.3.2. Flucytosine
6.3.3. Fluconazole
6.3.4. Others (Voriconazole, surgery treatment, etc.)
6.4. Global Cryptococcosis Market Attractiveness Analysis, by Treatment, 2014–2026
6.5. Key Trends

7. Global Cryptococcosis market Analysis, by Distribution Channel
7.1. Introduction
7.2. Key Findings
7.3. Global Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 -2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Drug Store
7.3.4. Mail Order Pharmacies
7.3.5. Others
7.4. Cryptococcosis Market Attractiveness Analysis, by Distribution Channel, 2014-2026
7.5. Key Trends

8. Global Cryptococcosis Market Analysis, by Region
8.1. Global Market Scenario by Country
8.2. Global Cryptococcosis Market Value Share Analysis, by Region, 2016 and 2026

9. North America Cryptococcosis Market Analysis
9.1. Key Findings
9.2. Market Overview
9.3. North America Cryptococcosis Market Value Share Analysis, by Country
9.4. North America Cryptococcosis Market Value Share Analysis, by Treatment
9.5. North America Cryptococcosis Market Value Share Analysis, by Distribution Channel
9.6. North America Cryptococcosis Market Attractiveness Analysis
9.7. Key Trends

10. Middle East & Africa Cryptococcosis Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Country
10.4. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Treatment
10.5. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Distribution Channel
10.6. Middle East & Africa Cryptococcosis Market Attractiveness Analysis
10.7. Key Trends

11. Asia Pacific Cryptococcosis Market Analysis
11.1. Key Findings
11.2. Asia Pacific Cryptococcosis Market Overview
11.3. Asia Pacific Cryptococcosis Market Value Share Analysis, by Country
11.4. Asia Pacific Cryptococcosis Market Value Share Analysis, by Treatment
11.5. Asia Pacific Cryptococcosis Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Cryptococcosis Market Attractiveness Analysis
11.7. Key Trends

12. Europe Cryptococcosis market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Europe Cryptococcosis Market Value Share Analysis, by Country
12.4. Europe Cryptococcosis Market Value Share Analysis, by Treatment
12.5. Europe Cryptococcosis Market Value Share Analysis, by Distribution Channel
12.6. Europe Cryptococcosis Market Attractiveness Analysis
12.7. Key Trends

13. Latin America Cryptococcosis market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Latin America Cryptococcosis Market Value Share Analysis, by Country
13.4. Latin America Cryptococcosis Market Value Share Analysis, by Treatment
13.5. Latin America Cryptococcosis Market Value Share Analysis, by Distribution Channel
13.6. Latin America Cryptococcosis Market Attractiveness Analysis
13.7. Key Trends

14. Competition Landscape
14.1. Cryptococcosis Market Share Analysis By Company, 2016 (Estimated)
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Bristol-Myers Squibb Company
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Janssen Biotech, Inc. (Johnson & Johnson)
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Abbott Laboratories
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Novartis AG
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Pfizer, Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Valeant Pharmaceuticals, Inc.
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. Glenmark Pharmaceuticals
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Viamet Pharmaceuticals, Inc.
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Sigmapharm Laboratories LLC
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis